Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS-CoV-2 mRNA vaccination.

Sebastian J Theobald, Alexander Simonis, Julie M Mudler, Ulrike Göbel, Richard Acton, Viktoria Kohlhas, Marie-Christine Albert, Anna-Maria Hellmann, Jakob J Malin, Sandra Winter, Michael Hallek, Henning Walczak, Phuong-Hien Nguyen, Manuel Koch, Jan Rybniker
Author Information
  1. Sebastian J Theobald: Department I of Internal Medicine, Faculty of Medicine, University of Cologne, Cologne, Germany.
  2. Alexander Simonis: Department I of Internal Medicine, Faculty of Medicine, University of Cologne, Cologne, Germany. ORCID
  3. Julie M Mudler: Department I of Internal Medicine, Faculty of Medicine, University of Cologne, Cologne, Germany. ORCID
  4. Ulrike Göbel: Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
  5. Richard Acton: Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany. ORCID
  6. Viktoria Kohlhas: Department I of Internal Medicine, Faculty of Medicine, University of Cologne, Cologne, Germany. ORCID
  7. Marie-Christine Albert: Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
  8. Anna-Maria Hellmann: Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine, University of Cologne, Cologne, Germany.
  9. Jakob J Malin: Department I of Internal Medicine, Faculty of Medicine, University of Cologne, Cologne, Germany. ORCID
  10. Sandra Winter: Department I of Internal Medicine, Faculty of Medicine, University of Cologne, Cologne, Germany.
  11. Michael Hallek: Department I of Internal Medicine, Faculty of Medicine, University of Cologne, Cologne, Germany.
  12. Henning Walczak: Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany. ORCID
  13. Phuong-Hien Nguyen: Department I of Internal Medicine, Faculty of Medicine, University of Cologne, Cologne, Germany. ORCID
  14. Manuel Koch: Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine, University of Cologne, Cologne, Germany. ORCID
  15. Jan Rybniker: Department I of Internal Medicine, Faculty of Medicine, University of Cologne, Cologne, Germany. ORCID

Abstract

Durable cell-mediated immune responses require efficient innate immune signaling and the release of pro-inflammatory cytokines. How precisely mRNA vaccines trigger innate immune cells for shaping antigen specific adaptive immunity remains unknown. Here, we show that SARS-CoV-2 mRNA vaccination primes human monocyte-derived macrophages for activation of the NLRP3 inflammasome. Spike protein exposed macrophages undergo NLRP3-driven pyroptotic cell death and subsequently secrete mature interleukin-1β. These effects depend on activation of Spleen tyrosine kinase (SYK) coupled to C-type lectin receptors. Using autologous cocultures, we show that SYK and NLRP3 orchestrate macrophage-driven activation of effector memory T cells. Furthermore, vaccination-induced macrophage priming can be enhanced with repetitive antigen exposure providing a rationale for prime-boost concepts to augment innate immune signaling in SARS-CoV-2 vaccination. Collectively, these findings identify SYK as a regulatory node capable of differentiating between primed and unprimed macrophages, which modulate Spike protein-specific T cell responses.

Keywords

Associated Data

GEO | GSE200274

References

  1. J Mol Biol. 2018 Jan 19;430(2):217-237 [PMID: 28987733]
  2. Nature. 2022 Jun;606(7914):576-584 [PMID: 35385861]
  3. OMICS. 2012 May;16(5):284-7 [PMID: 22455463]
  4. Nature. 2022 Jun;606(7914):585-593 [PMID: 35483404]
  5. Nature. 2008 Jun 19;453(7198):1122-6 [PMID: 18496530]
  6. Trends Immunol. 2006 Nov;27(11):511-7 [PMID: 16997631]
  7. Biotechnol J. 2015 Apr;10(4):647-53 [PMID: 25650551]
  8. Immunity. 2021 Jun 8;54(6):1304-1319.e9 [PMID: 34048708]
  9. FEBS J. 2018 Jul;285(13):2377-2401 [PMID: 29656546]
  10. Nat Med. 2013 Dec;19(12):1597-608 [PMID: 24309663]
  11. Cell. 2014 May 22;157(5):1013-22 [PMID: 24855941]
  12. Nature. 2008 May 29;453(7195):672-6 [PMID: 18496526]
  13. Nature. 2021 Oct;598(7880):342-347 [PMID: 34464958]
  14. Science. 2021 Dec 03;374(6572):abm0829 [PMID: 34648302]
  15. Nature. 2009 May 21;459(7245):433-6 [PMID: 19339971]
  16. Lancet. 2021 Dec 18;398(10318):2258-2276 [PMID: 34863358]
  17. Nat Rev Drug Discov. 2021 Jun;20(6):454-475 [PMID: 33824489]
  18. Nature. 2006 Mar 9;440(7081):228-32 [PMID: 16407890]
  19. Nat Biotechnol. 2020 Mar;38(3):276-278 [PMID: 32055031]
  20. Science. 2020 Sep 18;369(6510):1501-1505 [PMID: 32703906]
  21. Nature. 2021 Aug;596(7870):109-113 [PMID: 34182569]
  22. Front Immunol. 2021 Jan 27;11:621931 [PMID: 33584721]
  23. Immunity. 2011 May 27;34(5):651-64 [PMID: 21616435]
  24. Immunity. 2016 May 17;44(5):1052-68 [PMID: 27192569]
  25. Viruses. 2021 Oct 15;13(10): [PMID: 34696506]
  26. Biostatistics. 2017 Apr 1;18(2):275-294 [PMID: 27756721]
  27. Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50 [PMID: 16199517]
  28. Mol Cell Biol. 2005 Oct;25(19):8520-30 [PMID: 16166634]
  29. Sci Immunol. 2022 Jan 07;7(67):eabm5505 [PMID: 34995097]
  30. J Exp Med. 2009 Jan 16;206(1):79-87 [PMID: 19139171]
  31. Nat Rev Immunol. 2021 Apr;21(4):195-197 [PMID: 33674759]
  32. Nat Rev Immunol. 2019 Aug;19(8):477-489 [PMID: 31036962]
  33. Nat Rev Immunol. 2010 Jun;10(6):387-402 [PMID: 20467426]
  34. EMBO Mol Med. 2021 Aug 9;13(8):e14150 [PMID: 34133077]
  35. EMBO Mol Med. 2022 Aug 8;14(8):e15888 [PMID: 35785445]
  36. Sci Signal. 2021 Apr 27;14(680): [PMID: 33906973]
  37. Nat Rev Immunol. 2002 Apr;2(4):251-62 [PMID: 12001996]
  38. EBioMedicine. 2022 Jan;75:103803 [PMID: 34979342]
  39. Nature. 2011 Jan 13;469(7329):221-5 [PMID: 21124315]
  40. Nat Rev Immunol. 2016 Jul;16(7):407-20 [PMID: 27291964]

MeSH Term

COVID-19
COVID-19 Vaccines
Humans
Immunity, Innate
Inflammasomes
Interleukin-1beta
Intracellular Signaling Peptides and Proteins
NLR Family, Pyrin Domain-Containing 3 Protein
Protein-Tyrosine Kinases
RNA, Messenger
SARS-CoV-2
Spike Glycoprotein, Coronavirus
Syk Kinase
Vaccination

Chemicals

COVID-19 Vaccines
Inflammasomes
Interleukin-1beta
Intracellular Signaling Peptides and Proteins
NLR Family, Pyrin Domain-Containing 3 Protein
RNA, Messenger
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2
Protein-Tyrosine Kinases
Syk Kinase

Word Cloud

Created with Highcharts 10.0.0immuneinnatemRNASARS-CoV-2SYKsignalingvaccinationmacrophagesactivationresponsesvaccinescellsantigenadaptiveimmunityshowNLRP3inflammasometyrosinekinaseDurablecell-mediatedrequireefficientreleasepro-inflammatorycytokinespreciselytriggershapingspecificremainsunknownprimeshumanmonocyte-derivedSpikeproteinexposedundergoNLRP3-drivenpyroptoticcelldeathsubsequentlysecretematureinterleukin-1βeffectsdependspleencoupledC-typelectinreceptorsUsingautologouscoculturesorchestratemacrophage-driveneffectormemoryTFurthermorevaccination-inducedmacrophageprimingcanenhancedrepetitiveexposureprovidingrationaleprime-boostconceptsaugmentCollectivelyfindingsidentifyregulatorynodecapabledifferentiatingprimedunprimedmodulatespikeprotein-specificT cellSpleenmediatescrosstalk

Similar Articles

Cited By (8)